POS-273 Antihypertensive treatment with a hydrochlorothiazide-based regimen enhances medial vascular calcification in CKD rats with mineral bone disorders

POS-273 Antihypertensive treatment with a hydrochlorothiazide-based regimen enhances medial vascular calcification in CKD rats with mineral bone disorders

Bibliographic Details
Main Authors:	R. Lariviere, R.V. Ung, F. Mac-way, D. Richard, M. Agharazii
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024921004344

Similar Items

POS-272 DIFFERENTIAL EFFECTS OF ENDOTHELIN ETA RECEPTOR BLOCKADE ON VASCULAR CALCIFICATION AND RENAL INJURY IN RATS WITH CHRONIC KIDNEY DISEASE
by: R. Lariviere, et al.
Published: (2021-04-01)

CKD273, a new proteomics classifier assessing CKD and its prognosis.
by: Ángel Argilés, et al.
Published: (2013-01-01)

ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE
by: R. M. Linchak, et al.
Published: (2016-01-01)

EVALUATION OF ANTIHYPERTENSIVE THERAPY WITH THE COMBINATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
by: Steven G. Chrysant, et al.
Published: (2011-06-01)

Valvular calcifications in CKD: Mineral and bone disease or previous cardiovascular risk?
by: Alejandra Bocanegra-Jesús, et al.
Published: (2015-11-01)

Effects of diuretics furosemide and hydrochlorothiazide on CKD-MBD: A prospective randomized study
by: Raquel F.V. Vasco, et al.
Published: (2021-06-01)

Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?
by: Venu Gopal Jonnalagadda, et al.
Published: (2017-12-01)

Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination
by: O. D. Ostroumova, et al.
Published: (2019-09-01)

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker
by: Claudia Pontillo, et al.
Published: (2017-11-01)

Hypertension and antihypertensive agents in chronic kidney disease (CKD)
Published: (2014-01-01)

P144 IMPACT OF ANTI-HYPERTENSIVE DRUGS ON AORTIC STIFFNESS INDUCED BY CHRONIC KIDNEY DISEASE AND MINERAL BONE DISORDER IN RATS
by: Mohsen Agharazii, et al.
Published: (2018-12-01)

The Thermodynamics of Medial Vascular Calcification
by: Ángel Millán, et al.
Published: (2021-04-01)

Mineralization of Hydrochlorothiazide using Hydrogen Peroxide in Subcritical Water
by: Erdal Yabalak, et al.
Published: (2018-09-01)

Testing Vitamin D Analogues for Vascular Calcification in Patients With CKD
by: Madhuri Ramakrishnan, et al.
Published: (2020-07-01)

Revascularization in Mönckeberg medial calcific sclerosis
by: Jithin Jagan Sebastian, et al.
Published: (2020-01-01)

Effects of vitamin D receptor activators on vascular calcification in patients with CKD
by: Laycock, J. L.
Published: (2017)

The first results of an international clinical trial VICTORY:the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide usingdifferent dosage regimens in patients with 1-2 degree arterial hypertension
by: E Evgen'evna Chazova, et al.
Published: (2015-06-01)

Cortical unlike trabecular bone loss is not associated with vascular calcification progression in CKD patients
by: Larissa R. Costa, et al.
Published: (2020-04-01)

MicroRNAs Regulate Vascular Medial Calcification
by: Jane A. Leopold
Published: (2014-10-01)

The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide
by: O D Ostroumova, et al.
Published: (2016-12-01)

ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide
by: Ostroumova O.D., et al.
Published: (2016-12-01)

Validated stability-indicating HPLC-DAD method of analysis for the antihypertensive triple mixture of amlodipine besylate, valsartan and hydrochlorothiazide in their tablets
by: Rasha A. Shaalan, et al.
Published: (2017-02-01)

ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

A review of olmesartan medoxomil monotherapy: antihypertensive efficacy similar to that of other angiotensin II receptor blocker/hydrochlorothiazide combinations?
by: M. Greathouse
Published: (2011-10-01)

Editorial 27.3
by: Antônio José Lopes Alves
Published: (2018-12-01)

Intimal and medial calcification in relation to cardiovascular risk factors.
by: Sabine R Zwakenberg, et al.
Published: (2020-01-01)

Genome Sequence of Pseudomonas stutzeri 273 and Identification of the Exopolysaccharide EPS273 Biosynthesis Locus
by: Shimei Wu, et al.
Published: (2017-07-01)

POS-746 PRE-KIDNEY TRANSPLANT MEDIAL ARTERIAL CALCIFICATION AND POST-TRANSPLANT HYPERTENSION BY A PROPENSITY SCORE WEIGHTING
by: E. Tantisattamo, et al.
Published: (2021-04-01)

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension
by: Ravi Marfatia, et al.
Published: (2012-01-01)

Organ-protective effect of fixed-dose combination antihypertensive therapy with eprosartan and hydrochlorothiazide for subclinical and clinical target organ damage in hypertensive patients
by: N A Koziolova, et al.
Published: (2012-12-01)

Bisphophonates in CKD Patients with Low Bone Mineral Density
by: Wen-Chih Liu, et al.
Published: (2013-01-01)

POS-320 INSIDE ANEMIA OF CKD: QUANTIFYING THE EPIDEMIOLOGICAL BURDEN OF ANEMIA OF CKD IN CANADA VIA MICROSIMULATION MODELLING
by: J.J. GARCIA SANCHEZ, et al.
Published: (2021-04-01)

The Antihypertensive Efficacy of Chlorthalidone and Telmisartan in Indian Hypertensive Patients who were Uncontrolled with Hydrochlorothiazide and Telmisartan Combination-A Prospective and an Open Label Study
by: Suresh V Sagarad, et al.
Published: (2014-04-01)

Pré-textuais | Sumário 27.3
by: A. Vitor Guimarães
Published: (2018-12-01)

RECL 273 - 1-Jul-84
Published: (2011)

RECL 273 - 19-Aug-84
Published: (2011)

RECL 273 - 2-Aug-85
Published: (2011)

RECL 273 - 23-Jul-86
Published: (2011)

RECL 273 - 1-Jul-87
Published: (2011)